Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 2102-2103, 2003; 10.1373/clinchem.2003.024232
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blesa, J. R.
Right arrow Articles by Hernández-Yago, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blesa, J. R.
Right arrow Articles by Hernández-Yago, J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2003;49:2102-2103.)
© 2003 American Association for Clinical Chemistry, Inc.


Letters to the Editor

Detection of Hereditary Persistence of {alpha}-Fetoprotein by Conformation-sensitive Gel Electrophoresis Analysis

José R. Blesa1, José Vidal2, Remedios Giner-Durán2, María L. Lacalle1, Ignacio Catalán2 and José Hernández-Yago1,a

1 Fundación Valenciana, de Investigaciones Biomédicas, Instituto de Investigaciones Citológicas, Amadeo de Saboya, 4, 46010 Valencia, Spain
2 Hospital "Arnau de Vilanova", San Clemente 12, 46015 Valencia, Spain

aAddress correspondence to this author at: Fundación Valenciana de Investigaciones Biomédicas, Laboratory of Cell Organization, Amadeo de Saboya, 4, 46010 Valencia, Spain. Fax 34-963601453; e-mail hernan@ochoa.fib.es.

The first 20% of the full text of this article appears below.


To the Editor:

The concentration of human {alpha}-fetoprotein (AFP; MIM 104150) is used as a marker for several diseases in both adults and children, and it is also systematically measured in pregnant women as a marker of defects in the fetus.

In 1983, a case was discovered of a woman with high AFP expression that was shown to be attributable to a benign autosomal dominant genetic trait, hereditary persistence of AFP (HPAFP) (1). This syndrome shows high expression of AFP, but there is no association with any pathology. Failure to recognize HPAFP can lead to unsuitable treatments. For example, a 20-month-old child with HPAFP underwent surgery for a testicular germ cell tumor (2. . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
Y. Alj, E. Milgrom, and A. Guiochon-Mantel
Rapid Determination of {alpha}-Fetoprotein Gene Promoter Mutations in Hereditary Persistence of {alpha}-Fetoprotein
Clin. Chem., September 1, 2004; 50(9): 1706 - 1707.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.